av/astrazeneca--big.svg

NASDAQ:AZN

AstraZeneca plc

  • Stock

USD

Last Close

12,060.00

26/07 15:49

Market Cap

1.88B

Beta: 0.17

Volume Today

1.50M

Avg: 4.68M

PE Ratio

34.25

PFCF: 28.96

Dividend Yield

2.22%

Payout:75.97%

  • locale

    gbUnited Kingdom
  • market

    STOCKS
  • industry

    Drug Manufacturers - General
  • website

    www.astrazeneca.com
  • ipo date

    May 21, 1993

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/F...Show More

peer of

Earnings per Share (Estimate*)

0.20.40.60.812014-04-292016-04-292018-05-182020-04-292022-04-29

Revenue (Estimate*)

2B4B6B8B10B12B2014-04-292016-04-292018-05-182020-04-292022-04-29

*Estimate based on analyst consensus